HIGHLIGHTS
- who: Lin Ni et al. from the Department of General Surgery, TH Hospital of Joint Logistics Support Force (Fuzong Clinical Medical College) (Former Fuzhou General Hospital), Fuzhou, Fujian, China have published the research: GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma, in the Journal: Mediators of Inflammation 1.0 Actual 2-Year OS (proportion) of 19/04/2023
- what: The authors first analyzed the expression of GRP176 in STAD and explored the correlation with patient prognosis and various clinical features. In this study, a total of 371 STAD samples were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.